Form 8-K - Current report:
SEC Accession No. 0001104659-24-121025
Filing Date
2024-11-20
Accepted
2024-11-20 16:15:36
Documents
18
Period of Report
2024-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2426602d4_8k.htm   iXBRL 8-K 34267
2 EXHIBIT 1.1 tm2426602d4_ex1-1.htm EX-1.1 195067
3 EXHIBIT 4.2 tm2426602d4_ex4-2.htm EX-4.2 342253
4 EXHIBIT 5.1 tm2426602d4_ex5-1.htm EX-5.1 12287
8 GRAPHIC tm2426602d4_ex1-1img01.jpg GRAPHIC 3930
9 GRAPHIC tm2426602d4_ex4-2img001.jpg GRAPHIC 4679
  Complete submission text file 0001104659-24-121025.txt   887323

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gild-20241120.xsd EX-101.SCH 3009
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20241120_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20241120_pre.xml EX-101.PRE 22355
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2426602d4_8k_htm.xml XML 3561
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19731 | Film No.: 241480589
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)